Human primase synthesizes RNA primers and transfers them to the active site of Pol with subsequent extension with dNTPs. Human primase is a heterodimer of two subunits: a small catalytic subunit (p49) and a large subunit (p58). The structural details of the initiation and elongation steps of primer synthesis, as well as primer length counting, are not known. To address these questions, structural studies of human primase were initiated. Two types of crystals were obtained. The best diffracting crystals belonged to space group P1, with unit-cell parameters a = 86.2, b = 88.9, c = 94.68 Å , = 93.82, = 96.57, = 111.72 , and contained two heterodimers of full-length p49 and p59 subunits in the asymmetric unit.
Introduction
Almost all organisms depend on specialized DNA-dependent RNA polymerases, termed DNA primases, to initiate DNA synthesis de novo, which is critical for genome replication (Frick & Richardson, 2001; Kuchta & Stengel, 2009) . Primases are able to generate the RNA dinucleotide and extend it to the unit length of 7-10 nucleotides. The synthesis of RNA primers by eukaryotic primases includes steps of initiation, elongation and intramolecular transfer of the generated RNA primer to the active site of Pol , where it is extended with dNTPs (Pellegrini, 2012) . The eukaryotic primases are comprised of two subunits: a small catalytic subunit (p49 in human) and a large subunit (p58 in human). p58 plays an important role during all steps of primer synthesis (Klinge et al., 2007; Weiner et al., 2007; Copeland, 1997; Zerbe & Kuchta, 2002; Francesconi et al., 1991) . It contains an N-terminal domain (p58 N ) that binds p49 and a C-terminal domain (p58 C ) that coordinates the iron-sulfur cluster.
Currently, no structural information is available for eukaryotic primases, with the exception of p58 C (Sauguet et al., 2010; Vaithiyalingam et al., 2010; Agarkar et al., 2011) . In spite of low sequence identity, archaeal primases share some structural similarities with eukaryotic primases. The available structures of archaeal primases revealed the active-center architecture and the location of the NTPbinding site in the small subunit, as well as the arrangement of the subunits; however, the position of the functionally important C-terminal domain of the large subunit remains unknown (Augustin et al., 2001; Ito et al., 2003; Lao-Sirieix et al., 2005) . Here, we report the expression, purification and crystallization of the human primase p49-p58 complex consisting of full-length subunits and its truncated form p49-p58 1-457 .
Materials and methods
2.1. Cloning, expression and purification cDNAs for the p49 (420 amino acids) and p58 (509 amino acids) subunits of human primase were obtained from Open Biosystems (clone IDs 3686937 and 6148494, respectively). The constructs for the coexpression of p49-p58 and p49-p58 1-457 heterodimers from single plasmids were made in the following way. The DNA sequences coding for p58 or its truncated variant with a C-terminal 6ÂHis tag were amplified by PCR and cloned into pETDuet-1 vector (Novagen) at the NdeI/XhoI restriction sites; the DNA sequence for p49 was then cloned into the obtained plasmids using the NcoI/EcoRI sites. All plasmid constructs were verified by full-length sequencing. The full-length and truncated primases were expressed in Escherichia coli strain Rosetta 2(DE3) at 301 K for 15 h following induction with 1 mM IPTG at an OD 600 of 1 [0.1 mM ammonium iron(II) sulfate was added to the culture at the same time as the IPTG]. Bacterial cells were collected by centrifugation at 2000g, washed with PBS, collected by centrifugation at 6000g and kept frozen at 193 K. All purification steps were carried out on ice or at 277 K. The frozen cells were defrosted, resuspended in ten volumes of lysis buffer and disrupted using an EmulsiFlex-C5.
The p49-p58 complex was purified by two chromatographic steps. The cell pellet from 1 l culture was disrupted in buffer H consisting of 20 mM Tris-HCl pH 7.9, 0.25 M NaCl, 3% glycerol, 1 mM DTT, and the lysate was clarified by centrifugation at 40 000g for 20 min and by passage through a 0.22 mm membrane (Millipore). The lysate was loaded onto a 5 ml SP HiTrap HP column connected to two 5 ml Heparin HiTrap HP columns (all columns were from GE Healthcare) at a flow rate of 1 ml min À1 , and the columns were washed with 20 ml buffer H at a flow rate of 1.5 ml min À1 . The SP HiTrap column was then disconnected and the primase was eluted from the connected Heparin columns with a linear gradient of NaCl (150 ml, 0.25-1 M) in buffer H. The fractions corresponding to the primase peak eluting at $450 mM NaCl were combined and dialyzed to 0.1 M NaCl in buffer Q (20 mM Tris-HCl pH 7.9, 3% glycerol, 2 mM MgCl 2 , 1 mM DTT). After centrifugation at 20 000g for 10 min the supernatant was loaded at a flow rate of 1 ml min À1 onto a 5 ml Q HiTrap HP column equilibrated with buffer Q containing 0.15 M NaCl. The primase was eluted with a linear gradient of NaCl (75 ml, 0.15-0.6 M) in buffer Q at a flow rate of 1.5 ml min À1 . The peak fractions eluting at 0.26 M NaCl were combined and dialyzed to 10 mM HEPES-NaOH pH 7.2, 100 mM KCl, 1% glycerol, 2 mM MgCl 2 , 1 mM DTT. The purified and dialyzed p49-p58 complex was concentrated to 5 mg ml À1 , flashfrozen in liquid nitrogen and kept at 193 K.
The p49-p58 1-457 complex was purified by three chromatographic steps. The cell pellet from 5 l culture was disrupted in buffer N consisting of 50 mM HEPES-NaOH pH 6.9, 300 mM NaCl, 10% glycerol, 10 mM MgSO 4 , 10 mM -mercaptoethanol (-ME) and supplemented with 1 mM PMSF. After centrifugation at 40 000g for 20 min, 1% streptomycin sulfate was added to the lysate followed by incubation with gentle stirring for 20 min. The centrifugation step was repeated and the clarified lysate was loaded onto a 5 ml HisTrap HP column (GE Healthcare) at a flow rate of 1 ml min À1 . The column was then washed at a flow rate of 1.5 ml min À1 with 15 ml of the following buffers: (i) buffer N, (ii) 0.5 M NaCl in buffer N, (iii) 0.3 M NaCl and 60 mM imidazole-HCl in buffer N (pH 6.5) and (iv) buffer N. The bound fraction was eluted with a linear gradient of imidazole-HCl (75 ml, 60-150 mM) in buffer N at a flow rate of 1.5 ml min À1 . The peak primase fractions were combined according to purity analysis by 10% SDS-PAGE and loaded onto a 5 ml Heparin HiTrap HP column equilibrated with 50 mM HEPES-NaOH pH 6.9, 300 mM NaCl, 10 mM MgSO 4 , 10 mM -ME. The bound proteins were eluted with a linear gradient of NaCl (75 ml, 0.3-1 M) in equilibration buffer. The fractions corresponding to the peak eluting at $450 mM NaCl were combined and diluted with two volumes of 20 mM MES-NaOH pH 6.8, 10 mM MgCl 2 , 5 mM DTT. The obtained sample was loaded onto a 5 ml SP HiTrap HP column equilibrated with buffer S (20 mM MES-NaOH pH 6.8, 150 mM NaCl, 10 mM MgCl 2 , 5 mM DTT). The primase was eluted with a linear gradient of NaCl (75 ml, 0.15-0.6 M) in buffer S at a flow rate of 1.5 ml min À1 . The peak fractions were combined, concentrated to 5 mg ml À1 , flash-frozen in liquid nitrogen and kept at 193 K.
Crystallization
For the crystallization of the p49-p58 complex, the 0.1 ml aliquots were defrosted, centrifuged to remove the precipitate, and the quality of the sample was verified by dynamic light scattering (DLS). Initial crystallization screening was performed using the Crystal Screen and Crystal Screen 2 kits (Hampton Research) by the sitting-drop vapordiffusion method at 295 K by mixing 1 ml protein solution with 1 ml of the ethanol concentration. The best single rhomb-shaped plate crystals with a longest dimension of 0.08 mm were grown with a reservoir solution consisting of 50 mM Tris-HCl pH 8.5, 7.5%(v/v) ethanol, 2 mM TCEP. Further increases in crystal size to up to 0.7 mm in the longest dimension were achieved by macroseeding (Fig. 1a) . The crystal content was verified by SDS-PAGE and revealed both p49 and p58 subunits, as in a purified sample (Fig. 1b) .
For the crystallization of the p49-p58 1-457 complex, the 0.1 ml aliquots were defrosted, diluted with 2 ml 20 mM MES-NaOH pH 6.8, 50 mM KCl, 2.5 mM MgCl 2 , 2 mM TCEP and concentrated to 5.4 mg ml À1 . Initial crystallization screening was performed as described above. Small aggregated crystals appeared in condition No. 22 of the Crystal Screen 2 kit [0.1 M MES pH 6.5, 12%(w/v) PEG 20 000]. Optimization of this condition and screening of additives using the Additive Screen kit (Hampton Research) resulted in the growth of rods with a square cross-section (Fig. 1c) . The optimized reservoir solution consisted of 45 mM MES pH 6.5, 4.5%(w/v) PEG 20 000, 0.1%(v/v) MPD, 3%(v/v) tert-butanol, 4 mM trimethylamine, 1 mM TCEP. The content of the crystal was similar to that of the purified sample (Fig. 1d ).
X-ray diffraction data collection and processing
The crystal was soaked in cryoprotectant for a few seconds, scooped in a nylon-fiber loop and flash-cooled in a dry nitrogen stream at 100 K. For the p49-p58 crystals the cryoprotectant solution consisted of 50 mM Tris-HCl pH 8.5, 9%(v/v) ethanol, 30%(v/v) ethylene glycol, and for the p49-p58 1-457 crystals the cryoprotectant solution consisted of 45 mM MES pH 6.5, 5.5%(w/v) PEG 20 000, 2% tert-butanol, 15%(v/v) ethylene glycol, 10%(v/v) PEG 200. All initial diffraction data were obtained on a Rigaku R-AXIS IV imaging plate using Osmic VariMax HR mirror-focused Cu K radiation from a Rigaku FR-E rotating-anode generator operated at 45 kV and 45 mA. Complete diffraction data sets were collected using synchrotron X-rays on the Northeastern Collaborative Access Team (NE-CAT) beamlines at the Advanced Photon Source (APS). All intensity data were indexed, integrated and scaled with DENZO and SCALEPACK from the HKL-2000 program package (Otwinowski & Minor, 1997) . The crystal parameters and data-processing statistics are summarized in Table 1 .
Results and discussion
Human DNA primase complex with full-length p49 and p58 subunits produced crystals with triclinic lattice parameters that diffracted to 2.6 Å resolution using synchrotron X-rays (Table 1 ; Fig. 2a ). The area of the crystal free of visible defects was exposed during the full diffraction data-set collection (Fig. 1a ). Diffraction spots from the rest of the crystal were twinned or contained multiple satellites. All p49-p58 crystals had similar defects, allowing the collection of one diffraction data set from each crystal. Calculation of the self-rotation function using CNS (Brü nger et al., 1998) revealed a pseudo-twofold symmetry axis that is parallel to the unit-cell axis a, indicating the presence of two independent primase molecules in the asymmetric unit. Molecular-replacement searches, using known archaeal primase crystal structures or the crystal structure of human p58 iron-sulfurbinding domain as a search model, failed to produce a solution. However, the p49 subunit contains a conserved zinc-binding site and the p58 subunit contains an iron-sulfur cluster with four Fe ions. To obtain phases from zinc anomalous scattering, we collected a diffraction data set at the Zn K edge (1.2827 Å ). At this wavelength, the iron-sulfur clusters are also expected to provide a significant contribution to the anomalous signal for SAD phasing.
The crystals of p49-p58 1-457 are well shaped; however, unlike the p49-p58 crystals, the p49-p58 1-457 crystals diffracted poorly (Fig. 2b) . The elongated crystal shape and tetragonal symmetry allowed a complete diffraction data-set collection using one crystal by exposing it at 11 spots with high X-ray flux. The data were processed to 3.9 Å resolution. Systematic absences pointed to space group P4 1 or P4 3 . Calculation of the self-rotation function indicated the absence of pseudo-symmetry. Therefore, one primase molecule is located in the asymmetric unit and the crystal has a high solvent content of 82.3%. The structure will be determined by the molecular-replacement method using the coordinates of p49-p58. 
